These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37019859)

  • 1. Small Intestinal Bacterial Overgrowth Complicating Gastrointestinal Manifestations of Systemic Sclerosis: A Systematic Review and Meta-analysis.
    Shah A; Pakeerathan V; Jones MP; Kashyap PC; Virgo K; Fairlie T; Morrison M; Ghoshal UC; Holtmann GJ
    J Neurogastroenterol Motil; 2023 Apr; 29(2):132-144. PubMed ID: 37019859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis.
    Feng X; Li XQ; Jiang Z
    Clin Rheumatol; 2021 Aug; 40(8):3039-3051. PubMed ID: 33426631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Links between celiac disease and small intestinal bacterial overgrowth: A systematic review and meta-analysis.
    Shah A; Thite P; Hansen T; Kendall BJ; Sanders DS; Morrison M; Jones MP; Holtmann G
    J Gastroenterol Hepatol; 2022 Oct; 37(10):1844-1852. PubMed ID: 35734803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Shah A; Talley NJ; Jones M; Kendall BJ; Koloski N; Walker MM; Morrison M; Holtmann GJ
    Am J Gastroenterol; 2020 Feb; 115(2):190-201. PubMed ID: 31913194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal calprotectin in systemic sclerosis and review of the literature.
    Marie I; Leroi AM; Menard JF; Levesque H; Quillard M; Ducrotte P
    Autoimmun Rev; 2015 Jun; 14(6):547-54. PubMed ID: 25661980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome in systemic sclerosis: a potential therapeutic target.
    Polkowska-Pruszyńska B; Gerkowicz A; Rawicz-Pruszyński K; Krasowska D
    Postepy Dermatol Alergol; 2022 Feb; 39(1):101-109. PubMed ID: 35369617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Fecal Calprotectin in Patients with Systemic Sclerosis and Small Intestinal Bacterial Overgrowth (SIBO).
    Polkowska-Pruszyńska B; Gerkowicz A; Rawicz-Pruszyński K; Krasowska D
    Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32823752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small intestinal bacterial overgrowth in systemic sclerosis.
    Marie I; Ducrotté P; Denis P; Menard JF; Levesque H
    Rheumatology (Oxford); 2009 Oct; 48(10):1314-9. PubMed ID: 19696066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.
    Parodi A; Sessarego M; Greco A; Bazzica M; Filaci G; Setti M; Savarino E; Indiveri F; Savarino V; Ghio M
    Am J Gastroenterol; 2008 May; 103(5):1257-62. PubMed ID: 18422815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis.
    Gandhi A; Shah A; Jones MP; Koloski N; Talley NJ; Morrison M; Holtmann G
    Gut Microbes; 2021; 13(1):1933313. PubMed ID: 34190027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients.
    Sawadpanich K; Soison P; Chunlertrith K; Mairiang P; Sukeepaisarnjaroen W; Sangchan A; Suttichaimongkol T; Foocharoen C
    Int J Rheum Dis; 2019 Apr; 22(4):695-699. PubMed ID: 30729669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis.
    Chen B; Kim JJ; Zhang Y; Du L; Dai N
    J Gastroenterol; 2018 Jul; 53(7):807-818. PubMed ID: 29761234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Intestinal Bacterial Overgrowth in Functional Dyspepsia: A Systematic Review and Meta-Analysis.
    Gurusamy SR; Shah A; Talley NJ; Koloski N; Jones MP; Walker MM; Morrison M; Holtmann G
    Am J Gastroenterol; 2021 May; 116(5):935-942. PubMed ID: 33734110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms.
    Tauber M; Avouac J; Benahmed A; Barbot L; Coustet B; Kahan A; Allanore Y
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-82-7. PubMed ID: 25372792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease.
    Shah A; Morrison M; Burger D; Martin N; Rich J; Jones M; Koloski N; Walker MM; Talley NJ; Holtmann GJ
    Aliment Pharmacol Ther; 2019 Mar; 49(6):624-635. PubMed ID: 30735254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small intestinal bacterial overgrowth in systemic sclerosis: a review of the literature.
    Polkowska-Pruszyńska B; Gerkowicz A; Szczepanik-Kułak P; Krasowska D
    Arch Dermatol Res; 2019 Jan; 311(1):1-8. PubMed ID: 30382339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review.
    Pittman N; Rawn SM; Wang M; Masetto A; Beattie KA; Larché M
    Rheumatology (Oxford); 2018 Oct; 57(10):1802-1811. PubMed ID: 29982822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and meta-analysis: Small intestinal bacterial overgrowth in chronic pancreatitis.
    Capurso G; Signoretti M; Archibugi L; Stigliano S; Delle Fave G
    United European Gastroenterol J; 2016 Oct; 4(5):697-705. PubMed ID: 27733912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
    Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.